Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stress-induced cellular damage

dc.contributor.authorLee, B. S.en
dc.contributor.authorChen, J.en
dc.contributor.authorAngelidis, C.en
dc.contributor.authorJurivich, D. A.en
dc.contributor.authorMorimoto, R. I.en
dc.date.accessioned2015-11-24T18:59:01Z
dc.date.available2015-11-24T18:59:01Z
dc.identifier.issn0027-8424-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19335
dc.rightsDefault Licence-
dc.subjectDNA-Binding Proteins/genetics/*metabolismen
dc.subjectGene Expression/drug effectsen
dc.subjectHeLa Cellsen
dc.subjectHeat-Shock Proteins/genetics/*metabolismen
dc.subjectHot Temperatureen
dc.subjectHumansen
dc.subjectIndomethacin/*pharmacologyen
dc.subjectInflammation/drug therapy/genetics/metabolismen
dc.subjectPhosphorylationen
dc.subjectStress, Physiological/genetics/metabolismen
dc.subjectTranscription Factorsen
dc.titlePharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stress-induced cellular damageen
heal.abstractThe activation of heat shock genes by diverse forms of environmental and physiological stress has been implicated in a number of human diseases, including ischemic damage, reperfusion injury, infection, neurodegeneration, and inflammation. The enhanced levels of heat shock proteins and molecular chaperones have broad cytoprotective effects against acute lethal exposures to stress. Here, we show that the potent antiinflammatory drug indomethacin activates the DNA-binding activity of human heat shock transcription factor 1 (HSF1). Perhaps relevant to its pharmacological use, indomethacin pretreatment lowers the temperature threshold of HSF1 activation, such that a complete heat shock response can be attained at temperatures that are by themselves insufficient. The synergistic effect of indomethacin and elevated temperature is biologically relevant and results in the protection of cells against exposure to cytotoxic conditions.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/7638169-
heal.identifier.secondaryhttp://www.pnas.org/content/92/16/7207.full.pdf-
heal.journalNameProc Natl Acad Sci U S Aen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1995-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Πρωτότυπος φάκελος/πακέτο

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
Lee-1995-Pharmacological modu.pdf
Μέγεθος:
1.62 MB
Μορφότυπο:
Adobe Portable Document Format

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: